CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) [Phase 2]
Summary
Phase 2 trial evaluating mexiletine in sporadic amyotrophic lateral sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Sporadic Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2015-10-12